Journey Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Journey Medical Corp (DERM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $141.02 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-03-31
- Journey Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $141.02M.
- Journey Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $29.43K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2022-12-31 | $141.02M 10-K · filed 2023-03-31 |
| 2020-12-31 | $29.43K 10-K · filed 2022-03-28 |